Cargando…
Loss of Leucine-Rich Repeat Kinase 2 (LRRK2) in Rats Leads to Progressive Abnormal Phenotypes in Peripheral Organs
The objective of this study was to evaluate the pathology time course of the LRRK2 knockout rat model of Parkinson’s disease at 1-, 2-, 4-, 8-, 12-, and 16-months of age. The evaluation consisted of histopathology and ultrastructure examination of selected organs, including the kidneys, lungs, splee...
Autores principales: | Baptista, Marco A. S., Dave, Kuldip D., Frasier, Mark A., Sherer, Todd B., Greeley, Melanie, Beck, Melissa J., Varsho, Julie S., Parker, George A., Moore, Cindy, Churchill, Madeline J., Meshul, Charles K., Fiske, Brian K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3828242/ https://www.ncbi.nlm.nih.gov/pubmed/24244710 http://dx.doi.org/10.1371/journal.pone.0080705 |
Ejemplares similares
-
Inhibitors of Leucine Rich Repeat Kinase 2 (LRRK2) Protect Against LRRK2-Models of Parkinson’s Disease
por: Lee, Byoung Dae, et al.
Publicado: (2010) -
Function and dysfunction of leucine-rich repeat kinase 2 (LRRK2):
Parkinson’s disease and beyond
por: Bae, Jae Ryul, et al.
Publicado: (2015) -
Leucine-rich repeat kinase 2 (LRRK2) regulates α-synuclein clearance in microglia
por: Maekawa, Tatsunori, et al.
Publicado: (2016) -
The tale of proteolysis targeting chimeras (PROTACs) for Leucine‐Rich Repeat Kinase 2 (LRRK2)
por: Konstantinidou, Markella, et al.
Publicado: (2020) -
Leucine-Rich Repeat Kinase 2 (Lrrk2)-Sensitive Na(+)/K(+) ATPase Activity in Dendritic Cells
por: Hosseinzadeh, Zohreh, et al.
Publicado: (2017)